Canada Cancer Biomarker Market 2019 Growth, COVID Impact, Trends Analysis Report 2025

Canada cancer biomarker market is growing at a CAGR of 11.4% during the forecast period. The healthcare industry of the Canada depends heavily on the demand created by the publicly funded and insured health care system of the country. The medical device industry consists of companies that produce a wide range of products which are used for the diagnosis and treatment of ailments. Canada is one of the potential markets for cancer biomarker. Canada has a population of 36 million in 2018 which accounts to 0.48% of the total world’s population. The geriatric population accounts for a considerable patient pool having cancers, in turn influencing the Canada cancer biomarkers market.

To Request a Sample of our Report on Canada Cancer Biomarker Market:  https://www.omrglobal.com/request-sample/canada-cancer-biomarker-market

According to the Canadian Cancer Statistics it was estimated that around 1 in 2 Canadian will have cancer in life time. On the other hand, 1 out of 4 will die due to cancer. According to the organization in the year 2017, more than 206,000 people were suffering from cancer. Additionally, more than 80,000 cases of deaths due to cancer were registered. The lung cancer is the leading cause of deaths in Canada. 

Moreover, prostate cancer is one of the most prevalent cancer in Canadian men. It is the 3rd leading cause of mortality from cancer in men in Canada. Canadian Cancer Society estimated that around 21% of the new cancer cases in men will be diagnosed with prostate cancer that accounted for 21,300. It is estimated that 4100 mortalities will be recorded which will represent 10% of all mortalities from all cancers in 2017. On average 58 Canadian men will be diagnosed with prostate cancer every day and, 11 Canadian men will decrease from prostate cancer every day. Thus, the high prevalence creates scopes for the Canada cancer biomarker market during the forecast period.

(Get 15% Discount on Buying this Report)

A full Report of Canada Cancer Biomarker Market is Available @  https://www.omrglobal.com/industry-reports/canada-cancer-biomarker-market

Canada Cancer Biomarker Market Segmentation

By Biomarker Type

·        Genetic Biomarker

·        Protein Biomarker

By Cancer Type

·        Lung Cancer

·        Prostate Cancer

·        Breast Cancer

·        Colorectal Cancer

·        Cervical Cancer

·        Other

By Applications

·        Drug Discovery and Development

·        Diagnosis

·        Risk Assessment

·        Prognostics

By Profiling Technology

·        Omics Technology

·        Immunoassays

·        Cytogenetics

·        Bioinformatics

Company Profiles

·        Abbott laboratories Inc.

·        Astellas Pharma Inc.

·        Becton, Dickson and Co.

·        Bio-Rad Laboratories, Inc.

·        Danaher Corp.

·        F. Hoffmann-La Roche Ltd.

·        Merck and Co., Inc.

·        Novartis AG

·        Pfizer Inc.

·        QIAGEN GmbH

·        Thermo Fisher Scientific Inc.

Reasons to buy from us –

1.  We cover more than 15 major industries, further segmented into more than 90 sectors.

2.  More than 120 countries are for analysis.

3.  Over 100+ paid data sources mined for investigation.

4.  Our expert research analysts answer all your questions before and after purchasing your report.

About Orion Market Research 

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no:  +91 7803040404